Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Matthew Ku

Matthew Ku

MBBS, FRACP, FRCPA, PhD
St Vincent’s Hospital
A Phase Ib study of JNJ-90014496, a CD19/CD20 bispecific CAR-T therapy, in patients with R/R LBCL 4:43
A Phase Ib study of JNJ-90014496, a CD19/CD20 bispecific CAR-T therapy, in patients with R/R LBCL
Matthew Ku • 14 Jun 2025
Emerging options for the management of patients with DLBCL who relapse following CAR-T 1:30
Emerging options for the management of patients with DLBCL who relapse following CAR-T
Matthew Ku • 14 Jun 2025
The content of VJHemOnc is intended for healthcare professionals